NCCN guidelines recommend adjuvant chemotherapy for patients with stage 2 or 3 R0 resected NSCLC including 4 cycles of platinum based chemotherapy, but are there any situations (patient or tumor characteristics, choice of chemotherapy) where you would offer more?